These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 28849121

  • 21. PNMA1, regulated by miR-33a-5p, promotes proliferation and EMT in hepatocellular carcinoma by activating the Wnt/β-catenin pathway.
    Liu P, Chen B, Gu Y, Liu Q.
    Biomed Pharmacother; 2018 Dec; 108():492-499. PubMed ID: 30243081
    [Abstract] [Full Text] [Related]

  • 22. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
    Lin X, Zuo S, Luo R, Li Y, Yu G, Zou Y, Zhou Y, Liu Z, Liu Y, Hu Y, Xie Y, Fang W, Liu Z.
    Theranostics; 2019 Dec; 9(25):7583-7598. PubMed ID: 31695788
    [Abstract] [Full Text] [Related]

  • 23. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
    Ge C, Wu S, Wang W, Liu Z, Zhang J, Wang Z, Li R, Zhang Z, Li Z, Dong S, Wang Y, Xue Y, Yang J, Tan Q, Wang Z, Song X.
    Oncotarget; 2015 May 10; 6(13):10964-77. PubMed ID: 25844602
    [Abstract] [Full Text] [Related]

  • 24. MicroRNA-542-3p inhibits the growth of hepatocellular carcinoma cells by targeting FZD7/Wnt signaling pathway.
    Wu W, Dang S, Feng Q, Liang J, Wang Y, Fan N.
    Biochem Biophys Res Commun; 2017 Jan 01; 482(1):100-105. PubMed ID: 27815069
    [Abstract] [Full Text] [Related]

  • 25. Expression of Cancer Stem Cell-associated DKK1 mRNA Serves as Prognostic Marker for Hepatocellular Carcinoma.
    Sakabe T, Azumi J, Umekita Y, Toriguchi K, Hatano E, Hirooka Y, Shiota G.
    Anticancer Res; 2017 Sep 01; 37(9):4881-4888. PubMed ID: 28870909
    [Abstract] [Full Text] [Related]

  • 26. MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma.
    Zhang Q, Zhao S, Pang X, Chi B.
    Oncol Rep; 2016 Mar 01; 35(3):1831-40. PubMed ID: 26677080
    [Abstract] [Full Text] [Related]

  • 27. CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/β-catenin pathway.
    Tan A, Li Q, Chen L.
    Arch Biochem Biophys; 2019 Jan 01; 661():196-202. PubMed ID: 30468709
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4.
    Chouhan S, Singh S, Athavale D, Ramteke P, Pandey V, Joseph J, Mohan R, Shetty PK, Bhat MK.
    Sci Rep; 2016 Jun 08; 6():27558. PubMed ID: 27272409
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. MiR-26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β-catenin signaling.
    Hu X, Wang R, Ren Z, Liu X, Gu J, Cui G, Li Q.
    Cancer Med; 2019 Dec 08; 8(17):7359-7371. PubMed ID: 31637871
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Downregulation of DNMT3A by miR-708-5p Inhibits Lung Cancer Stem Cell-like Phenotypes through Repressing Wnt/β-catenin Signaling.
    Liu T, Wu X, Chen T, Luo Z, Hu X.
    Clin Cancer Res; 2018 Apr 01; 24(7):1748-1760. PubMed ID: 28972040
    [Abstract] [Full Text] [Related]

  • 36. MGAT1 is a novel transcriptional target of Wnt/β-catenin signaling pathway.
    Akiva I, Birgül Iyison N.
    BMC Cancer; 2018 Jan 08; 18(1):60. PubMed ID: 29310626
    [Abstract] [Full Text] [Related]

  • 37. Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma.
    Jia P, Wei G, Zhou C, Gao Q, Wu Y, Sun X, Li X.
    Technol Cancer Res Treat; 2018 Jan 01; 17():1533034618765221. PubMed ID: 29618288
    [Abstract] [Full Text] [Related]

  • 38. COLEC10 inhibits the stemness of hepatocellular carcinoma by suppressing the activity of β-catenin signaling.
    Cai MN, Chen DM, Chen XR, Gu YR, Liao CH, Xiao LX, Wang JL, Lin BL, Huang YH, Lian YF.
    Cell Oncol (Dordr); 2024 Oct 01; 47(5):1897-1910. PubMed ID: 39080215
    [Abstract] [Full Text] [Related]

  • 39. Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway.
    Jin B, Wang W, Meng XX, Du G, Li J, Zhang SZ, Zhou BH, Fu ZH.
    BMC Cancer; 2016 Nov 08; 16(1):863. PubMed ID: 27821157
    [Abstract] [Full Text] [Related]

  • 40. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX, Qi Y, Zhang J, Liu Y, Xu WH, Xu J, Hu HG, Wu QY, Wang Y, Zhang JP.
    Oncotarget; 2016 Nov 29; 7(48):79544-79556. PubMed ID: 27783993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.